Nasal Decongestion and Obstructive Sleep Apnea
clinical trial
Press Enter · cited answer in seconds
0 sources
Summary
Nasal Decongestion and Obstructive Sleep Apnea is a clinical trial[1].
Key Facts
- Nasal Decongestion and Obstructive Sleep Apnea is in the country of Switzerland[2].
- Nasal Decongestion and Obstructive Sleep Apnea's instance of is recorded as clinical trial[3].
- Nasal Decongestion and Obstructive Sleep Apnea's start time is recorded as +2004-01-31T00:00:00Z[4].
- Nasal Decongestion and Obstructive Sleep Apnea's end time is recorded as +2005-04-30T00:00:00Z[5].
- Nasal Decongestion and Obstructive Sleep Apnea's sponsor is recorded as University of Zurich[6].
- Nasal Decongestion and Obstructive Sleep Apnea's main subject is recorded as apnea[7].
- Nasal Decongestion and Obstructive Sleep Apnea's main subject is recorded as rhinitis[8].
- Nasal Decongestion and Obstructive Sleep Apnea's number of participants is recorded as {'unit': '1', 'amount': '+12'}[9].
- Nasal Decongestion and Obstructive Sleep Apnea's title is recorded as Does Nasal Decongestion Improve Obstructive Sleep Apnea ?[10].
- Nasal Decongestion and Obstructive Sleep Apnea's minimum age is recorded as {'unit': 'http://www.wikidata.org/entity/Q577', 'amount': '+20'}[11].
- Nasal Decongestion and Obstructive Sleep Apnea's ClinicalTrials.gov ID is recorded as NCT00630474[12].
- Nasal Decongestion and Obstructive Sleep Apnea's maximum age is recorded as {'unit': 'http://www.wikidata.org/entity/Q577', 'amount': '+75'}[13].
- Nasal Decongestion and Obstructive Sleep Apnea's research intervention is recorded as xylometazoline[14].
- Nasal Decongestion and Obstructive Sleep Apnea's clinical trial phase is recorded as phase IV clinical trial[15].
- Nasal Decongestion and Obstructive Sleep Apnea's research site is recorded as University of Zurich[16].
- Nasal Decongestion and Obstructive Sleep Apnea's study type is recorded as interventional study[17].